Environmental neurotoxicity in early life: nodding syndrome as a model of neurodevelopmental priming and neurodegenerative vulnerability

Nodding syndrome (NS) is a childhood-onset epileptic disorder reported in sub-Saharan Africa, characterized by seizures, developmental delay, progressive neurological decline, and tau pathology. Its rapid clinical progression provides an opportunity to investigate how early developmental vulnerability may intersect with neurodegenerative processes. We reanalyzed cerebrospinal fluid (CSF) proteomic data from Ugandan patients with NS ( n = 9) and age-comparable controls ( n = 9) to identify molecular signatures associated with this convergence. Differential protein abundance implicated proteostasis, bioenergetics, genomic and epigenetic regulation, and structural and neurovascular integrity. Reduced abundance of PP1/PP2A-associated components and V-ATPase subunits, together with increased lysosomal hydrolases, suggested disturbances in phosphoregulatory and lysosomal homeostasis. Changes in developmental and cytoskeletal proteins further implicated neuronal maturation and structural stability. These signatures showed molecular parallels with MECP2 -related disorders and lysosomal tauopathies, without implying a shared etiology. Collectively, the findings support a testable model in which compromised metabolic and proteostatic resilience may link developmental vulnerability to progressive neurological dysfunction. Malnutrition, infections, and regionally relevant environmental biotoxins may contribute to this convergence, although their involvement was not directly assessed. Despite the small cohort and the inferential limits of CSF proteomics, this study provides a molecular basis for investigating the neurodevelopmental-neurodegenerative continuum in NS and testing whether early molecular signatures can predict disease trajectories. The model prioritizes homeostatic resilience as a potential determinant of neurological health and a target for future preventive research.

Authors

Institutions

Publication Details

Journal
Frontiers in Neurology
Published
2026-11-13
DOI
https://doi.org/10.3389/fneur.2026.1863021
Primary Topic
Epilepsy research and treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Environmental neurotoxicity in early life: nodding syndrome as a model of neurodevelopmental priming and neurodegenerative vulnerability

Phillip A. Wilmarth, Ashok P. Reddy, Raquel Valdes Angues, Keith D. Zientek et al.
3 links
Frontiers in Neurology
Epilepsy research and treatment
article

Environmental neurotoxicity in early life: nodding syndrome as a model of neurodevelopmental priming and neurodegenerative vulnerability

Phillip A. Wilmarth, Ashok P. Reddy, Raquel Valdes Angues, Keith D. Zientek, Peter S. Spencer, Valerie S. Palmer
article en

Abstract

Nodding syndrome (NS) is a childhood-onset epileptic disorder reported in sub-Saharan Africa, characterized by seizures, developmental delay, progressive neurological decline, and tau pathology. Its rapid clinical progression provides an opportunity to investigate how early developmental vulnerability may intersect with neurodegenerative processes. We reanalyzed cerebrospinal fluid (CSF) proteomic data from Ugandan patients with NS ( n = 9) and age-comparable controls ( n = 9) to identify molecular signatures associated with this convergence. Differential protein abundance implicated proteostasis, bioenergetics, genomic and epigenetic regulation, and structural and neurovascular integrity. Reduced abundance of PP1/PP2A-associated components and V-ATPase subunits, together with increased lysosomal hydrolases, suggested disturbances in phosphoregulatory and lysosomal homeostasis. Changes in developmental and cytoskeletal proteins further implicated neuronal maturation and structural stability. These signatures showed molecular parallels with MECP2 -related disorders and lysosomal tauopathies, without implying a shared etiology. Collectively, the findings support a testable model in which compromised metabolic and proteostatic resilience may link developmental vulnerability to progressive neurological dysfunction. Malnutrition, infections, and regionally relevant environmental biotoxins may contribute to this convergence, although their involvement was not directly assessed. Despite the small cohort and the inferential limits of CSF proteomics, this study provides a molecular basis for investigating the neurodevelopmental-neurodegenerative continuum in NS and testing whether early molecular signatures can predict disease trajectories. The model prioritizes homeostatic resilience as a potential determinant of neurological health and a target for future preventive research.

Frontiers in NeurologyVol. 17
Oregon Health & Science University (US)
Good health and well-being
Epilepsy research and treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon